Hongyue Zhou

Xinjiang Street 125
Changchun, 130021, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Generation of ultra-intense vortex laser from a binary phase square spiral zone plate.

Generation of ultra-intense vortex laser from a binary phase square spiral zone plate.

Journal: Optics express

Published: March 05, 2024

ScAlN Film-Based Piezoelectric Micromechanical Ultrasonic Transducers with Dual-Ring Structure for Distance Sensing.

ScAlN Film-Based Piezoelectric Micromechanical Ultrasonic Transducers with Dual-Ring Structure for Distance Sensing.

Journal: Micromachines

Published: January 29, 2023

The development of catalysts for electrochemical nitrogen reduction toward ammonia: theoretical and experimental advances.

The development of catalysts for electrochemical nitrogen reduction toward ammonia: theoretical and experimental advances.

Journal: Chemical communications (Cambridge, England)

Published: August 31, 2022

TRAF6-overexpressing dendritic cells loaded with MUC1 peptide enhance anti-tumor activity in B16-MUC1 melanoma-bearing mice.

TRAF6-overexpressing dendritic cells loaded with MUC1 peptide enhance anti-tumor activity in B16-MUC1 melanoma-bearing mice.

Journal: International immunopharmacology

Published: January 05, 2022

Recombinant MUC1-MBP fusion protein combined with CpG2006 vaccine induces antigen-specific CTL responses through cDC1-mediated cross-priming mainly regulated by type I IFN signaling in mice.

Recombinant MUC1-MBP fusion protein combined with CpG2006 vaccine induces antigen-specific CTL responses through cDC1-mediated cross-priming mainly regulated by type I IFN signaling in mice.

Journal: Immunology letters

Published: November 04, 2021

Anti-PD1 antibody enhances the anti-tumor efficacy of MUC1-MBP fusion protein vaccine via increasing Th1, Tc1 activity and decreasing the proportion of MDSC in the B16-MUC1 melanoma mouse model.

Anti-PD1 antibody enhances the anti-tumor efficacy of MUC1-MBP fusion protein vaccine via increasing Th1, Tc1 activity and decreasing the proportion of MDSC in the B16-MUC1 melanoma mouse model.

Journal: International immunopharmacology

Published: July 05, 2021

Dual roles of myeloid-derived suppressor cells induced by Toll-like receptor signaling in cancer.

Dual roles of myeloid-derived suppressor cells induced by Toll-like receptor signaling in cancer.

Journal: Oncology letters

Published: July 26, 2020

The Effect of Different Immunization Cycles of a Recombinant Mucin1-Maltose-Binding Protein Vaccine on T Cell Responses to B16-MUC1 Melanoma in Mice.

The Effect of Different Immunization Cycles of a Recombinant Mucin1-Maltose-Binding Protein Vaccine on T Cell Responses to B16-MUC1 Melanoma in Mice.

Journal: International journal of molecular sciences

Published: July 13, 2020

CpG ODN1826 as a Promising Mucin1-Maltose-Binding Protein Vaccine Adjuvant Induced DC Maturation and Enhanced Antitumor Immunity.

CpG ODN1826 as a Promising Mucin1-Maltose-Binding Protein Vaccine Adjuvant Induced DC Maturation and Enhanced Antitumor Immunity.

Journal: International journal of molecular sciences

Published: February 13, 2018

The combination of maltose-binding protein and BCG-induced Th1 activation is involved in TLR2/9-mediated upregulation of MyD88-TRAF6 and TLR4-mediated downregulation of TRIF-TRAF3.

The combination of maltose-binding protein and BCG-induced Th1 activation is involved in TLR2/9-mediated upregulation of MyD88-TRAF6 and TLR4-mediated downregulation of TRIF-TRAF3.

Journal: Cellular immunology

Published: October 16, 2017

Showing 1-10 of 10

Last Updated: 09/26/2026